[Pleco: Obtained New Veterinary Drug Registration Certificate for Newcastle Disease and Other Triple Inactivated Vaccine] On November 10, Pleco (603566.SH) announced that the "Chicken Newcastle Disease, Avian Influenza (H9 Subtype), Infectious Rhinitis (Type A, B, C) Triple Inactivated Vaccine" jointly applied by the company and its wholly-owned subsidiary Huizhong Biotech was approved as a new veterinary drug by the Ministry of Agriculture and Rural Affairs, and a "New Veterinary Drug Registration Certificate" was issued. This vaccine is the first of its kind in the world and can prevent chicken Newcastle disease, avian influenza and chicken infectious rhinitis, achieving multiple preventions with one shot. As of now, there is no similar multi-conjugate vaccine for poultry on the market. This product needs to obtain a veterinary drug product approval number before going on the market. Obtaining the certificate will enrich the company's poultry vaccine product categories, enhance competitiveness, and bring new performance growth points.